Smruthi Organics (BOM:540686) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:540686 Smruthi Organics Ltd BOM:540686
68 GF Score
Price ₹118.80
GF Value ₹107.46
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Smruthi Organics Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Smruthi Organics's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

BOM:540686 vs ZTS, UTHR: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Smruthi Organics's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Smruthi Organics Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Smruthi Organics's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Smruthi Organics's Margin of Safety % (DCF Earnings Based) falls into.


BOM:540686
68GF Score
Smruthi Organics Ltd BOM:540686
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Smruthi Organics (BOM:540686) Overvalued in 2026?

Based on GuruFocus' analysis, Smruthi Organics stock appears to be overvalued. The current stock price of ₹118.80 is trading 10.6% above its estimated GF Value™ of ₹107.46. GuruFocus considers Smruthi Organics to be Modestly Overvalued.

Key valuation signals for BOM:540686:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹107.46 vs. price of ₹118.80 (10.6% above fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the BOM:540686 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Smruthi Organics Business Description

Address Railway Lines, 165-A, 1st Floor, Balaji Bhavan, Solapur, MH, IND, 413001
Smruthi Organics Ltd is engaged in the manufacture of bulk drugs and drug intermediates (API Products). The product portfolio includes Amlodipine Besilate, Amlodipine Base, S-Amlodipine Besilate, S-Amlodipine Base, Norfloxacin, Metformin HCI, Diloxanide Furoate, Phthaloyl Amlodipine, Pantoprazole Sodium, Pefloxacin Mesylate Dihydrate, Telmisartan, Losartan Potassium, and many more. It has two reportable business segments: Bulk Drugs and Drugs Intermediates (API), and Formulation. It generates the majority of its revenue from the Bulk Drugs and Drugs Intermediates (API) segment. Geographically, the company generates maximum revenue from outside India through exports, and the rest from its business within India.
68GF Score

Get the complete analysis for BOM:540686

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹118.80
Price
₹107.46
GF Value